Germ line<i>DDX41</i>mutations define a unique subtype of myeloid neoplasms
Hideki Makishima(Kyoto University), Jaroslaw P. Maciejewski(Cleveland Clinic), Pramila Krishnamurthy(King's College London), Yasunobu Nagata(Kyoto University), Sophia C. Korotev(Robert H. Lurie Comprehensive Cancer Center of Northwestern University), Takayuki Ishikawa(Kobe City Medical Center General Hospital), Joop H. Jansen(Radboud University Nijmegen), Akifumi Takaori‐Kondo(Kyoto University), Carsten Müller‐Tidow(Heidelberg University), Ayana Kon(Kyoto University), Yotaro Ochi(Kyoto University), Toru Kiguchi(Chugoku Central Hospital), Hisashi Tsurumi(Matsunami General Hospital), Yuichi Shiraishi(The University of Tokyo), Kenichi Yoshida(Kyoto University), Ryunosuke Saiki(Kyoto University), Masashi Sanada(Nagoya Medical Center), Fumihiko Matsuda(Kyoto University), Torsten Haferlach(Martin Luther Christian University), Kenichi Chiba(The University of Tokyo), Austin Kulasekararaj(King's College London), Yoshiko Atsuta(The Japanese Data Center for Hematopoietic Cell Transplantation), Takuto Mori(Kyoto University), Nobuyuki Kakiuchi(Kyoto University), Yuka Iijima‐Yamashita(Nagoya Medical Center), Mario Cazzola(Roche (Switzerland)), Masahiro Nakagawa(NTT (Japan)), Kazuma Ohyashiki(Tokyo Medical University), Piers Blombery(The University of Melbourne), June Takeda(Kyoto University), Rurika Okuda(Kyoto University), Carmelo Gurnari(University of Rome Tor Vergata), Senji Kasahara(Gifu Municipal Hospital), Lucy A. Godley(University of Chicago), Yasuhito Nannya(Kyoto University), Shigeru Chiba(University of Tsukuba), Akinori Yoda(Kyoto University), Yasushi Miyazaki(Nagasaki University), Luca Malcovati(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Michiaki Kubo(RIKEN Center for Integrative Medical Sciences), Makoto Onizuka(Tokai University), Tetsuichi Yoshizato(Kyoto University), Chantana Polprasert(Chulalongkorn University), Satoru Miyano(Cardiovascular Institute Hospital), Hiroko Tanaka(The University of Tokyo), Yusuke Shiozawa(Kyoto University), Yukihide Momozawa(RIKEN Center for Integrative Medical Sciences), Steve Best(King's College London), Hidehiro Itonaga(Nagasaki University)
Cited by 142
Related Papers
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
|Cancer Cell|2010|2.7k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
A cross-population atlas of genetic associations for 220 human phenotypes
|Nature Genetics|2021|2.4k